Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 28
Filter
1.
J Clin Microbiol ; 38(5): 1791-6, 2000 May.
Article in English | MEDLINE | ID: mdl-10790101

ABSTRACT

AmpC beta-lactamases are cephalosporinases that confer resistance to a wide variety of beta-lactam drugs and that may thereby create serious therapeutic problems. Although reported with increasing frequency, the true rate of occurrence of AmpC beta-lactamases in Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis remains unknown. We tested a total of 1,286 consecutive, nonrepeat isolates of these three species and found that, overall, 45 (3.5%) yielded a cefoxitin zone diameter less than 18 mm (screen positive) and that 16 (1.2%) demonstrated AmpC bands by isoelectric focusing. Based on the species, of 683 E. coli, 371 K. pneumoniae, and 232 P. mirabilis isolates tested, 13 (1.9%), 28 (7.6%), and 4 (1.7%), respectively, demonstrated decreased zone diameters and 11 (1.6%), 4 (1.1%), and 1 (0.4%), respectively, demonstrated AmpC bands. Cefoxitin resistance was transferred for all but 8 (E. coli) of the 16 AmpC producers. We also describe a three-dimensional extract test, which was used to detect phenotypically isolates that harbor AmpC beta-lactamase. Of the 45 cefoxitin-resistant isolates, the three-dimensional extract test accurately identified all 16 AmpC producers and 28 of 29 (97%) isolates as non-AmpC producers. Interestingly, most (86%) isolates in the latter group were K. pneumoniae isolates. These data confirm that, at our institution, E. coli, K. pneumoniae, and P. mirabilis harbor plasmid-mediated AmpC enzymes.


Subject(s)
Bacterial Proteins , Cefoxitin/pharmacology , Escherichia coli/enzymology , Klebsiella pneumoniae/enzymology , Proteus mirabilis/enzymology , beta-Lactamases/analysis , Escherichia coli/drug effects , Escherichia coli/isolation & purification , Hospitals, Veterans , Humans , Klebsiella pneumoniae/drug effects , Klebsiella pneumoniae/isolation & purification , Microbial Sensitivity Tests , Proteus mirabilis/drug effects , Proteus mirabilis/isolation & purification , United States
2.
J Antimicrob Chemother ; 43(5): 659-66, 1999 May.
Article in English | MEDLINE | ID: mdl-10382887

ABSTRACT

The mechanism of bismuth's bactericidal activity against Helicobacter pylori was investigated using transmission electron microscopy (TEM) and analytical electron microscopy (AEM); time-kill kinetic methods evaluated the effect of excess divalent cations. TEM analysis of untreated H. pylori revealed a normal morphology. In contrast, H. pylori exposed to bismuth salts had swollen, distorted cells with membrane-cell wall blebbing and a cytoplasm containing electron-dense, sometimes crystalline aggregates. By AEM, swollen cells contained bismuth at the cell periphery, whereas bacillary forms contained cytoplasmic bismuth localizations. Time-kill studies showed that the bactericidal activity of bismuth could be prevented by pretreatment with divalent cations. The effects of bismuth salts on the glycocalyces-cell walls of H. pylori with reversal of bactericidal activity by divalent cations are identical to those produced by other polycationic agents on various gram-negative bacilli. We conclude that disruption of the glycocalyces-cell walls of H. pylori is one mechanism of action for bismuth salts.


Subject(s)
Anti-Bacterial Agents/pharmacology , Bismuth/pharmacology , Helicobacter pylori/drug effects , Helicobacter pylori/ultrastructure , Organometallic Compounds/pharmacology , Cell Wall/drug effects , Cell Wall/ultrastructure , Glycocalyx/drug effects , Glycocalyx/ultrastructure , Kinetics , Microscopy, Electron/methods , Time Factors
3.
J Antimicrob Chemother ; 42(5): 657-60, 1998 Nov.
Article in English | MEDLINE | ID: mdl-9848452

ABSTRACT

Increasing metronidazole resistance suggests the need for alternative antibiotics for combination therapy of Helicobacter pylori infections. We evaluated a metronidazole-resistant and a clarithromycin-resistant strain of H. pylori under stationary growth phase conditions that favoured physiological conditions in order to determine if nitrofurantoin might be a suitable alternative for metronidazole in combination therapy. The results demonstrated that the triple combination of bismuth, tetracycline and nitrofurantoin achieved greater bactericidal activity against these two strains than did the combination of bismuth, tetracycline and metronidazole. These results suggest that further evaluation is warranted.


Subject(s)
Anti-Bacterial Agents/pharmacology , Helicobacter pylori/drug effects , Metronidazole/pharmacology , Nitrofurantoin/pharmacology , Antacids/pharmacology , Bismuth/pharmacology , Clarithromycin/pharmacology , Drug Resistance, Microbial , Drug Therapy, Combination , Helicobacter Infections/drug therapy , Helicobacter Infections/microbiology , Helicobacter pylori/growth & development , Humans , Tetracycline/pharmacology
4.
Diagn Microbiol Infect Dis ; 32(1): 39-44, 1998 Sep.
Article in English | MEDLINE | ID: mdl-9791756

ABSTRACT

We evaluated the in vitro bactericidal effect of clarithromycin versus ampicillin alone and in combination against clarithromycin-sensitive and clarithromycin-resistant strains of Helicobacter pylori. No combination containing clarithromycin achieved complete bactericidal effect against clarithromycin-resistant strains. Complete bactericidal effect was achieved for all strains by triple-agent combinations that contained bismuth, omeprazole, and relatively high concentrations of ampicillin. These in vitro results demonstrate the additive bactericidal activity provided by a combination of agents for the eradication of H. pylori. Bismuth may play a particularly important role in the bactericidal effect.


Subject(s)
Ampicillin/pharmacology , Anti-Bacterial Agents/pharmacology , Bismuth/pharmacology , Clarithromycin/pharmacology , Helicobacter pylori/drug effects , Omeprazole/pharmacology , Pyloric Antrum/microbiology , Drug Interactions , Drug Resistance, Microbial , Helicobacter pylori/isolation & purification , Humans , Microbial Sensitivity Tests , Sensitivity and Specificity , Species Specificity
5.
J Clin Microbiol ; 35(10): 2593-7, 1997 Oct.
Article in English | MEDLINE | ID: mdl-9316913

ABSTRACT

A total of 907 consecutive isolates of members of the family Enterobacteriaceae recovered during a 20-week period were tested for production of extended-spectrum beta-lactamases (ESBLs) by the double-disk (DD) potentiation method. Of 84 DD-positive isolates, 83 (9.2%) produced ESBLs based on isoelectric focusing. SHV-derived ESBLs and several TEM-derived ESBLs were present in nine species, including the first isolate of Citrobacter koserii and Morganella morganii known to harbor an SHV-derived ESBL. Results of testing 58 nonrepeat isolates for ESBL production by several recommended methods were as follows (percent detected in parentheses): DD method with aztreonam (95), ceftazidime (79), ceftriaxone (88), or cefpodoxime (90); broth microdilution method with ceftazidime (86) or cefotaxime (91) alone or in combination with clavulanate; and the standard disk diffusion method with new breakpoints and standard concentrations of aztreonam (78), ceftazidime (79), ceftriaxone (83), or cefpodoxime (98) or a novel concentration (5 microg) of ceftazidime (88). In three instances during an extended part of the study, an ESBL-producing isolate and a non-ESBL-producing isolate of the same species were recovered from a single blood culture bottle. These data indicate that ESBLs occur in several species of Enterobacteriaceae and at a relatively high incidence at our institution and that the standard disk diffusion method with cefpodoxime and the DD method with several beta-lactams are practical and cost-effective methods for detecting ESBL-producing isolates of Enterobacteriaceae.


Subject(s)
Enterobacteriaceae/enzymology , beta-Lactamases/metabolism , beta-Lactams/metabolism , Aztreonam/metabolism , Aztreonam/pharmacology , Ceftazidime/metabolism , Ceftazidime/pharmacology , Ceftizoxime/analogs & derivatives , Ceftizoxime/metabolism , Ceftizoxime/pharmacology , Ceftriaxone/metabolism , Ceftriaxone/pharmacology , Enterobacteriaceae/classification , Enterobacteriaceae/isolation & purification , Hospitals, Veterans , Isoelectric Focusing , Microbial Sensitivity Tests , Species Specificity , Substrate Specificity , beta-Lactam Resistance/physiology , Cefpodoxime
6.
J Clin Microbiol ; 34(8): 1892-6, 1996 Aug.
Article in English | MEDLINE | ID: mdl-8818876

ABSTRACT

Twenty-three beta-lactamase (beta-lac)-producing, highly gentamicin-resistant Enterococcus faecalis isolates collected over a 7-year period from the same hospital were examined by pulsed-field gel electrophoresis of SmaI-digested genomic DNA. The beta-lac+ isolates appeared to form a single clonal group, which had been previously designated the mid-Atlantic pattern. Eleven variations of the mid-Atlantic clone, differing by one to six bands, were identified; some of the changes were likely due to plasmid bands. However, a number of isolates had indistinguishable patterns, including some recovered over a 4-year period. There was a surprising lack of movement of the beta-lac determinant to other strains, although this trait was transferable in vitro by conjugation. We conclude that a single clone (the mid-Atlantic clone) of beta-lac+ E. faecalis has remained endemic in this hospital for at least 7 years. The reason(s) for the apparent lack of spread to other strains of E. faecalis is unknown.


Subject(s)
Cross Infection/microbiology , Enterococcus faecalis/genetics , Gram-Positive Bacterial Infections/microbiology , Polymorphism, Restriction Fragment Length , beta-Lactamases/biosynthesis , Anti-Bacterial Agents/pharmacology , Cross Infection/epidemiology , DNA Restriction Enzymes , Drug Resistance, Microbial/genetics , Electrophoresis, Gel, Pulsed-Field , Enterococcus faecalis/classification , Enterococcus faecalis/enzymology , Gentamicins/pharmacology , Gram-Positive Bacterial Infections/epidemiology , Hospitals , Plasmids/genetics , Specimen Handling
7.
Antimicrob Agents Chemother ; 39(12): 2641-4, 1995 Dec.
Article in English | MEDLINE | ID: mdl-8592994

ABSTRACT

Optimal therapy for Helicobacter pylori infection to date, consists of metronidazole, bismuth, and tetracycline. This combination, however, is less effective against metronidazole-resistant organisms. We used a time-kill kinetic methodology to assess the bactericidal effects of selected agents, alone and in combination, to a metronidazole-susceptible and a metronidazole-resistant strain of H. pylori. single, double, and triple agents showed increasing bactericidal activity. The combination of metronidazole, bismuth, and tetracycline showed maximal killing effect (no detectable regrowth) against the susceptible strain, but against the resistant strain this combination showed less killing. The time-kill methodology may therefore offer an in vitro approach to the initial selection of agents to be evaluated for the treatment of H. pylori infections.


Subject(s)
Anti-Bacterial Agents/pharmacology , Drug Therapy, Combination/pharmacology , Helicobacter pylori/drug effects , Metronidazole/pharmacology , Drug Resistance, Microbial , Microbial Sensitivity Tests , Time Factors
8.
J Clin Microbiol ; 33(4): 1028-30, 1995 Apr.
Article in English | MEDLINE | ID: mdl-7790430

ABSTRACT

In order to increase the database for in vitro growth and/or susceptibility testing in liquid media, we evaluated the growth of Helicobacter pylori in broth media containing 5% sheep blood. We also compared the effect of bismuth on the growth of H. pylori in broth media containing 10% fetal calf serum with the effect on growth in media containing 0.5% starch. In contrast to the result seen with agar, we found that sheep blood, whether whole or laked, inhibited the growth of H. pylori in broth media. In addition, we found that bismuth inhibited growth in media with starch but that this inhibition was negated in media with serum.


Subject(s)
Bacteriological Techniques , Culture Media , Helicobacter pylori/drug effects , Helicobacter pylori/growth & development , Microbial Sensitivity Tests/methods , Agar , Animals , Bismuth , Blood , Cattle , Evaluation Studies as Topic , Helicobacter Infections/microbiology , Helicobacter pylori/isolation & purification , Humans , Sheep , Starch
9.
Antimicrob Agents Chemother ; 39(1): 66-9, 1995 Jan.
Article in English | MEDLINE | ID: mdl-7695331

ABSTRACT

Assessment of in vitro susceptibility testing of Helicobacter pylori is difficult because of the fastidious, slowly growing nature of this microorganism. The high rate of relapse observed clinically and a possible subpopulation of cells that are not actively replicating suggest the potential need for bactericidal therapy in order to eradicate H. pylori. We used modified time-kill kinetic methodology in order to evaluate the bactericidal activities of ampicillin and bismuth, alone and in combination, against three strains of H. pylori in both a stationary (slow) growth phase and a logarithmic (rapid) growth phase. We found that ampicillin produced a decrease in CFU per milliliter (2 to 4 log10 units) for three strains of H. pylori when tested in logarithmic growth phases but was less inhibitory (< 1-log10-unit decrease in CFU per milliliter) when tested in a stationary growth phase. In contrast, bismuth, when tested in a logarithmic growth phase, produced little inhibitory effect, as the CFU for all strains tested increased above the inoculum. However, when tested in a stationary growth phase, bismuth produced a decrease in CFU per milliliter of < 1 to > 3 log10 units). The activities of these two agents when combined mimicked the activity of the most active drug alone for that growth phase. We conclude that the clinical use of ampicillin combined with bismuth has been more effective than that of either agent used alone because ampicillin targets replicating cells, whereas bismuth targets cells that are not actively replicating.


Subject(s)
Ampicillin/pharmacology , Bismuth/pharmacology , Helicobacter pylori/drug effects , Drug Combinations , Drug Evaluation , Helicobacter pylori/growth & development , Kinetics , Microbial Sensitivity Tests , Time Factors
10.
Antimicrob Agents Chemother ; 37(7): 1447-51, 1993 Jul.
Article in English | MEDLINE | ID: mdl-8363374

ABSTRACT

Increasing antibiotic resistance in the enterococci, including the capacity for beta-lactamase production and the development of high-level aminoglycoside resistance, has complicated the treatment of serious enterococcal infections, which often require synergistic antibiotic combinations for cure. We utilized the rabbit model of aortic valve endocarditis to investigate the effects of various antibiotics, alone and in combination, against a multiply antibiotic-resistant isolate of Enterococcus faecalis. Female New Zealand White rabbits were infected with either a beta-lactamase-producing, gentamicin-resistant isolate of E. faecalis or a non-beta-lactamase-producing, aminoglycoside-susceptible isolate, and the mean log10 CFU per gram of vegetation were determined. The most active agents were low-dose ampicillin-sulbactam (200 mg/kg of body weight per day), high-dose ampicillin-sulbactam (400 mg/kg of body weight per day), and vancomycin (150 mg/kg of body weight per day), which reduced the titers of bacteria by 2.27, 2.76, and 2.85 log10 (CFU/g, respectively, compared with controls. While ampicillin-sulbactam and vancomycin were equally efficacious in reducing titers of bacteria in vegetations, no animals were cured (defined as < 2 log10 CFU/g of vegetation) by either agent, whether treatment was continued for 3 or 7 days. The addition of gentamicin was not associated with increased killing in rabbits infected with the aminoglycoside-resistant isolate. Both high-dose ampicillin-sulbactam and vancomycin regimens demonstrated significant, continued reduction in bacterial titers with the longer periods of treatment (P < or = 0.05); 7-day treatment with high-dose ampicillin-sulbactam produced a greater reduction in bacterial titers in vegetation than 7-day treatment with vancomycin (P < or = 0.05). We conclude that ampicillin-sulbactam and vancomycin are equally effective in the treatment of experimental endocarditis due to beta-lactamase-producing, highly gentamicin-resistant E. faecalis. The optimum therapy for such infections in humans is not known.


Subject(s)
Ampicillin/pharmacology , Drug Therapy, Combination/pharmacology , Endocarditis, Bacterial/drug therapy , Enterococcus faecalis/enzymology , Gentamicins/pharmacology , Gram-Positive Bacterial Infections/drug therapy , Sulbactam/pharmacology , Vancomycin/pharmacology , Ampicillin/blood , Animals , Aortic Valve/microbiology , Disease Models, Animal , Drug Resistance, Microbial , Drug Therapy, Combination/blood , Endocarditis, Bacterial/blood , Endocarditis, Bacterial/microbiology , Female , Gram-Positive Bacterial Infections/blood , Gram-Positive Bacterial Infections/microbiology , Rabbits , Sulbactam/blood , Vancomycin/blood , beta-Lactamases/biosynthesis , beta-Lactamases/metabolism
11.
J Clin Microbiol ; 30(11): 2757-61, 1992 Nov.
Article in English | MEDLINE | ID: mdl-1333477

ABSTRACT

Molecular typing methods were compared by using 66 ampicillin-resistant, non-beta-lactamase-producing Enterococcus faecium clinical isolates from diverse geographic areas. Whole-plasmid analysis, restriction enzyme analysis of plasmid DNA with EcoRI and HindIII, and contour-clamped homogeneous electric field electrophoresis with digestion by SmaI and ApaI were performed on all isolates. Whole-plasmid analysis identified 47 different groups. Restriction enzyme analysis of plasmid DNA identified 50 groups when EcoRI was used and 51 groups when HindIII was used. Results with EcoRI and HindIII differed in 9 of 66 isolates. Grouping results with whole-plasmid analysis differed from results of restriction enzyme analysis of plasmid DNA (combining EcoRI and HindIII) in 20 of 66 isolates. Contour-clamped homogeneous electric field electrophoresis identified 46 groups when SmaI was used and 44 groups when ApaI was used. Results with SmaI and ApaI differed in 3 of 66 isolates. Grouping results with contour-clamped homogeneous electric field electrophoresis (combining SmaI and ApaI) differed from results of restriction enzyme analysis of plasmid DNA (combining EcoRI and HindIII) in 17 of 66 isolates. The combined use of whole-plasmid analysis, restriction enzyme analysis of plasmid DNA with two enzymes, and contour-clamped homogeneous electric field electrophoresis with two restriction enzymes should be considered when E. faecium is typed for epidemiologic investigation.


Subject(s)
Enterococcus faecium/classification , Ampicillin Resistance , Bacterial Typing Techniques , DNA Restriction Enzymes , DNA, Bacterial/genetics , Electrophoresis , Enterococcus faecium/genetics , Enterococcus faecium/isolation & purification , Gram-Positive Bacterial Infections/epidemiology , Gram-Positive Bacterial Infections/microbiology , Humans , Plasmids , beta-Lactamases/biosynthesis
12.
Antimicrob Agents Chemother ; 36(5): 1125-6, 1992 May.
Article in English | MEDLINE | ID: mdl-1510404

ABSTRACT

Beta-Lactamase-producing, aminoglycoside-resistant strains of Enterococcus faecalis have been isolated from different geographic areas and are endemic at our institution. We report the isolation of a beta-lactamase-producing, aminoglycoside-resistant strain of E. faecium. The beta-lactamase was plasmid mediated and transferable with high frequency into a plasmid-free E. faecalis recipient strain. MICs suggested that the E. faecium strain also contained intrinsic (chromosomal) resistance to penicillins.


Subject(s)
Anti-Bacterial Agents/pharmacology , Enterococcus faecium/isolation & purification , Aminoglycosides , Drug Resistance, Microbial , Enterococcus faecium/drug effects , Enterococcus faecium/enzymology , Humans , Microbial Sensitivity Tests , beta-Lactamases/biosynthesis
13.
Ann Intern Med ; 116(4): 285-92, 1992 Feb 15.
Article in English | MEDLINE | ID: mdl-1733382

ABSTRACT

OBJECTIVE: To investigate the risk factors, clinical features, molecular epidemiology, and treatment outcomes associated with an outbreak of infections due to beta-lactamase-producing, high-level gentamicin-resistant Enterococcus faecalis. DESIGN: Case-control and molecular genetics study. SETTING: Tertiary care Veterans Affairs hospital. PATIENTS: Sixty-five patients infected or colonized with beta-lactamase-producing high-level gentamicin-resistant E. faecalis (case patients) were matched and compared with 65 randomly selected patients infected or colonized with beta-lactamase-negative, gentamicin-susceptible E. faecalis. MEASUREMENTS AND MAIN RESULTS: During the 20-month study period, 124 of 1506 isolates (8.2%) of E. faecalis from 70 patients were found to produce beta-lactamase. Univariate analysis showed older age, higher APACHE II score, nosocomial acquisition, recent surgical procedure, total parenteral nutrition, and antibiotic treatment to be significantly associated with the acquisition of beta-lactamase-producing, high-level gentamicin-resistant E. faecalis. A multivariate analysis, done using stepwise multiple logistic regressions, showed that only two variables remained significant: an APACHE II score greater than 6 (odds ratio, 9.5; 95% CI, 4.4 to 20.3) and antibiotic treatment (odds ratio, 10.2; CI, 4.5 to 23.2). The mortality rate for case patients was 7.7% (5 of 65 patients; CI, 1.2% to 14.2%); no control patient died. Of 23 infections occurring in case patients, 13 were treated with "inappropriate" antibiotics (regimens that included a beta-lactamase-unstable antibiotic); 2 patients improved and 11 had complete resolution of disease. "Appropriate" treatments (regimens that included a beta-lactamase-stable antibiotic) were used in 10 patients; 5 of 10 infections were fatal. Restriction enzyme digests of total chromosomal DNA showed nearly identical patterns for selected isolates of beta-lactamase-producing, high-level gentamicin-resistant E. faecalis, suggesting dissemination through the hospital of a single strain of E. faecalis. CONCLUSIONS: Fatal infections were observed despite treatment with beta-lactamase-stable antibiotics. The risk for infection or colonization with beta-lactamase-producing, high-level gentamicin-resistant E. faecalis was strongly associated with severe underlying disease (acute physiology and chronic health evaluation [APACHE] II score, greater than 6) and previous antibiotic treatment. These results may be useful in targeting high-risk patients for infection-control interventions.


Subject(s)
Cross Infection/microbiology , Enterococcus faecalis , Gentamicins/pharmacology , Gram-Positive Bacterial Infections/microbiology , beta-Lactamases/biosynthesis , Case-Control Studies , Disease Outbreaks , Drug Resistance, Microbial , Electrophoresis, Gel, Pulsed-Field , Enterococcus faecalis/drug effects , Enterococcus faecalis/enzymology , Enterococcus faecalis/genetics , Gram-Positive Bacterial Infections/epidemiology , Hospital Bed Capacity, 500 and over , Hospitals, Veterans , Humans , Middle Aged , Treatment Outcome , Virginia
14.
Invest Ophthalmol Vis Sci ; 32(10): 2696-9, 1991 Sep.
Article in English | MEDLINE | ID: mdl-1894469

ABSTRACT

Diphtheroids, members of the coryneform family of bacteria, increasingly have been recognized as the cause of serious ocular diseases. After isolation of coryneform group A-4 from two patients with delayed endophthalmitis after cataract extraction and intraocular lens implantation, 10(7) organisms were injected into the vitreous of seven New Zealand white rabbits, producing endophthalmitis in all eyes inoculated. Coryneform group A-4 subsequently was isolated in six of seven eyes receiving 10(7) organisms, proving Koch's postulates. Five of these seven eyes were treated with a single dose of intravitreal gentamicin, and three eyes remained culture positive. Eyes inoculated with 10(5) or 10(2) coryneform group A-4 organisms had transient anterior chamber and vitreal inflammation; all vitreous cultures were negative. These studies demonstrate that coryneform group A-4 endophthalmitis can be reproduced in an animal model and that gentamicin may not sterilize an eye infected with this organism. Future studies are needed to determine the optimum antibiotic regimen for treatment of this type of endophthalmitis.


Subject(s)
Corynebacterium Infections/drug therapy , Endophthalmitis/microbiology , Eye Infections, Bacterial/drug therapy , Animals , Disease Models, Animal , Endophthalmitis/drug therapy , Fundus Oculi , Gentamicins/therapeutic use , Rabbits , Vitreous Body/drug effects , Vitreous Body/microbiology
15.
J Clin Microbiol ; 29(9): 1777-9, 1991 Sep.
Article in English | MEDLINE | ID: mdl-1774295

ABSTRACT

An organism resembling Bacillus alvei was isolated from the lung and pleural fluid of an immunocompetent patient. The isolate differed from the type strain of B. alvei in its ability to reduce nitrate and its inability to produce dihydroxyacetone and acetylmethylcarbinol. The isolate was resistant to ciprofloxacin and showed intermediate susceptibility to vancomycin.


Subject(s)
Bacillaceae Infections/microbiology , Bacillus/isolation & purification , Empyema/microbiology , Pneumonia/microbiology , Bacillaceae Infections/drug therapy , Bacillus/classification , Bacillus/drug effects , Empyema/drug therapy , Humans , Male , Middle Aged , Penicillin V/therapeutic use , Pneumonia/drug therapy , Species Specificity
16.
Antimicrob Agents Chemother ; 35(6): 1075-80, 1991 Jun.
Article in English | MEDLINE | ID: mdl-1929246

ABSTRACT

beta-Lactamase-producing (BL+), aminoglycoside-resistant (AR) Enterococcus faecalis is endemic in our hospital, having caused widespread colonization and infection. Suitable therapy for infections caused by these organisms has been problematic. We compared the antimicrobial and bactericidal activities, by broth macrodilution and time-kill methods, of several antibiotics, alone and in combination, against BL+, AR isolates of E. faecalis and determined the transmissibility of antibiotic resistance markers. Ampicillin-sulbactam, imipenem, daptomycin, and ciprofloxacin were the most active antibiotics with MICs for 90% of isolates tested of 2, 1, 2, and 1 microgram/ml, respectively, against inocula of 10(3) and 10(5) CFU/ml. Little inoculum effect was noted with imipenem, vancomycin, daptomycin, or ciprofloxacin, while the addition of sulbactam to ampicillin partially inhibited the effect of the increased inoculum. Penicillin-sulbactam and ampicillin-sulbactam combinations in a 2:1 ratio were most frequently bactericidal (greater than or equal to 3-log10-unit decrease in bacterial titers at 24 h for 13 of 20 isolates), followed by daptomycin (8 of 20 isolates) and ciprofloxacin (2 of 20 isolates). Bactericidal activity was not demonstrated for imipenem or teicoplanin. beta-Lactamase production and aminoglycoside resistance were associated with a 60- to 65-MDa plasmid which was easily transferred to a plasmid-free E. faecalis recipient. The 840-bp beta-lactamase gene probe hybridized to purified plasmid DNA from BL+ donor isolates of E. faecalis and transconjugants but not from BL- isolates. Ampicillin-sulbactam and daptomycin (an investigational antibiotic) seem to be reasonable choices for the empiric therapy of presumed enterococcal infections in hospitals in which BL+, AR E. faecalis strains are isolated. Their use should ideally be supported by tests for bactericidal activity.


Subject(s)
Anti-Bacterial Agents/pharmacology , Drug Resistance, Microbial/genetics , Enterococcus faecalis/drug effects , beta-Lactamases/biosynthesis , Aminoglycosides , Conjugation, Genetic , DNA, Bacterial/isolation & purification , Enterococcus faecalis/enzymology , Enterococcus faecalis/genetics , Microbial Sensitivity Tests , Nucleic Acid Hybridization , Plasmids , Restriction Mapping , beta-Lactamases/genetics
17.
Arch Ophthalmol ; 108(7): 942-4, 1990 Jul.
Article in English | MEDLINE | ID: mdl-2369352

ABSTRACT

Recent clinical studies have emphasized the importance of diphtheroids, previously regarded as nonpathogenic bacteria or contaminants, as causes of ocular disease. We encountered two patients with endophthalmitis following cataract extraction and anterior chamber intraocular lens implantation. Both patients had previously been treated with subconjunctival and/or oral corticosteroids for presumed sterile endophthalmitis. Vitreous cultures in each case yielded pure growth of a diphtheroid that was subsequently identified as coryneform group A-4. The clinical response to standard intraocular therapy with gentamicin and cefazolin was delayed, although both patients eventually had restoration of functional vision. A comparison of the antibiotic minimum inhibitory and minimum bactericidal concentrations of the isolates may help to explain the delayed response to therapy seen in these two patients.


Subject(s)
Corynebacterium Infections , Endophthalmitis/etiology , Aged , Cataract Extraction , Cefazolin/therapeutic use , Corynebacterium Infections/drug therapy , Endophthalmitis/pathology , Female , Gentamicins/therapeutic use , Humans , Lenses, Intraocular , Penicillins/therapeutic use , Postoperative Complications
18.
J Clin Microbiol ; 28(1): 8-10, 1990 Jan.
Article in English | MEDLINE | ID: mdl-2298880

ABSTRACT

An organism resembling Corynebacterium striatum was isolated from the blood of a patient with acute aortic valvular insufficiency and no history of valvular heart disease. At autopsy, histopathologic examination of the aortic valve revealed pleomorphic gram-positive bacilli and destruction of valvular tissue. Our isolate differed from other nondiphtherial corynebacteria, including the type strain of C. striatum (ATCC 6940), in its ability to reduce nitrite. Nitrite reduction may be useful for distinguishing strains of corynebacteria.


Subject(s)
Aortic Valve , Corynebacterium Infections/microbiology , Endocarditis, Bacterial/microbiology , Aged , Corynebacterium/isolation & purification , Corynebacterium/metabolism , Corynebacterium Infections/pathology , Endocarditis, Bacterial/pathology , Heart Valve Diseases/microbiology , Heart Valve Diseases/pathology , Humans , Male , Nitrites/metabolism
19.
J Clin Microbiol ; 27(7): 1527-30, 1989 Jul.
Article in English | MEDLINE | ID: mdl-2475524

ABSTRACT

Thirty-nine single antral biopsies (phase 1) and 99 sets of six antral biopsies (phase 2) were collected from 132 patients, and 87 (63%) yielded positive cultures for Campylobacter pylori. Of several primary media tested in phase 1, tryptic soy agar and Skirrow agar, each supplemented with 10% whole sheep blood, supported relatively good growth of C. pylori. In phase 2, four of the six biopsies in each set were tested with different urease systems. Selective urea agar for rapid identification was the most sensitive (39 of 63 [62%] at 1 h) and specific (100%); however, the difference between this system and the CLOtest was not statistically significant. The remaining two biopsies, one transported in saline and the other transported in a supplemented tryptic soy broth, were ground separately and inoculated onto tryptic soy agar and Skirrow agar, each supplemented with 10% whole sheep blood. In selected instances, 10% horse serum or 10% horse serum and 5 mM urea or 1% cholesterol were also added to the media. Smears stained with a modified Gram stain or acridine orange detected 68% of 63 culture-positive biopsies; no false-positive results were reported. Skirrow agar supported better growth of C. pylori than did tryptic soy agar; the nonselective medium was also overgrown with contaminants in 25 to 30% of the positive cultures. Based on colony size, Skirrow agar supplemented with 10% whole sheep blood, 10% horse serum, and 1% cholesterol supported optimal growth of C. pylori. Fresh media supported better growth than did prepoured commercial media (P less than or equal to 0.004). Saline was a convenient and satisfactory transport medium for antral biopsies.


Subject(s)
Campylobacter Infections/microbiology , Campylobacter/isolation & purification , Gastritis/microbiology , Stomach/microbiology , Acridine Orange , Biopsy , Campylobacter/enzymology , Campylobacter/growth & development , Culture Media , Gastroscopy , Gentian Violet , Humans , Phenazines , Predictive Value of Tests , Pyloric Antrum , Staining and Labeling , Urease/analysis
20.
Am J Med ; 83(5): 949-52, 1987 Nov.
Article in English | MEDLINE | ID: mdl-3314500

ABSTRACT

Because of the immunosuppressive therapy received by patients undergoing cardiac transplantation, disseminated infections, including disseminated fungal infections, often develop. Disseminated coccidioidomycosis developed in a 23-year-old man soon after undergoing orthotopic cardiac transplantation. Clinical manifestations included an unusual rash, severe myositis and arthropathy, a rapid downhill course, and pathologic evidence of widespread fungal invasion, including invasion of the cardiac graft. Detailed travel and geographic histories, and perhaps skin testing and antibody determinations for geographic-specific pathogens, should be part of the preoperative evaluation of all transplant candidates.


Subject(s)
Coccidioidomycosis/etiology , Heart Transplantation , Immunosuppression Therapy/adverse effects , Adult , Cardiomyopathy, Dilated/therapy , Humans , Male , Risk Factors , Travel
SELECTION OF CITATIONS
SEARCH DETAIL
...